This Week in Pediatrics — May 14, 2026

Welcome to This Week in Pediatrics. This week we're covering 10 notable papers spanning advances in genetics and neurodevelopment, the long-term consequences of the perinatal period, and new insights into preventing and managing infectious diseases. Let's dive in.

Our first theme explores the rapidly moving field of genetics and neurodevelopment, with papers highlighting a new therapeutic strategy for a severe epilepsy, a novel genetic link to autism, a critical safety warning for gene therapy, and the foundational role of nutrition.

We begin with a paper in Science Translational Medicine that offers a proof-of-concept for gene editing in Dravet syndrome [10], a severe neurodevelopmental disorder caused by loss-of-function variants in the SCN1A gene.

The Study Investigators used an adenine base editor, or ABE, to directly correct a recurrent pathogenic variant. They delivered the ABE system using a dual adeno-associated virus serotype 9, or AAV9, into a mouse model that recapitulates key features of Dravet syndrome.

Results Neonatal treatment resulted in efficient editing, with 59% DNA correction and 97% mRNA correction in the neocortex. This molecular fix had profound functional consequences, restoring normal sodium currents and excitability in parvalbumin-expressing inhibitory neurons. Clinically, the treated mice had fewer spontaneous and temperature-induced seizures. Most strikingly, survival at 45 days improved dramatically from just 27% in vehicle-treated mice to 90% in the ABE-treated group. Treatment in older, 12-day-old mice also significantly improved survival.

Conclusions These preclinical data validate a strategy for correcting SCN1A variants with base editing and highlight the enormous potential of precision genome editing for Dravet syndrome and other single-gene neurodevelopmental disorders.

From therapy to etiology, a paper in Nature identifies a new potential genetic driver for autism spectrum disorder [5].

The Study Researchers analyzed whole-genome sequencing data from over 9,000 cases of ASD and 8,000 controls. They identified microdeletions on the X-chromosome implicating a long non-coding RNA called PTCHD1-AS as a new ASD-susceptibility gene. These deletions were found in 27 males with ASD, conferring roughly a 2.5-fold increased risk.

Results To explore its function, they created knockout mouse models. Male mice lacking Ptchd1-as displayed core ASD-like features, including increased repetitive behaviors and impaired social communication. Notably, these mice did not have the cognitive comorbidities or ADHD-like behaviors often seen with other ASD-related genes. The gene was found to be expressed in the dorsal striatum, and its disruption altered myelination and synaptic plasticity pathways.

Conclusions This study implicates a non-protein-coding gene in the etiology of autism, potentially defining a subtype of ASD characterized by core social and behavioral features without broader cognitive impairment. It opens a new avenue for understanding the molecular basis of ASD.

However, the promise of gene-based therapies, like the AAV vectors used in the Dravet study, is tempered by a sobering case report in The New England Journal of Medicine [9].

The Report This paper details the case of a 5-year-old boy with severe mucopolysaccharidosis type I, or Hurler syndrome, who had received intracisternal magna administration of an AAV9 gene therapy at one year of age. Four years after the treatment, he developed a neuroepithelial tumor.

Findings While the primary tumor was successfully resected and the child's cognitive function remains advanced for his age, suggesting the therapy had a beneficial effect on his underlying MPSI, molecular analysis of the tumor was deeply concerning. It revealed clonal integration of the AAV vector into the PLAG1 gene, a known oncogene, leading to the expression of a chimeric AAV-PLAG1 transcript. This provides direct evidence of insertional oncogenesis following AAV gene therapy in a human.

Implications While AAV vectors are considered predominantly non-integrating, this case confirms that rare integration events can occur and can have devastating consequences. It underscores the absolute necessity of long-term monitoring and further research into the safety of vector-based gene therapies.

This week's focus on neurodevelopment is rounded out by a review in Pediatric Research on the role of choline [7]. Choline is an essential nutrient critical for cell membranes, the neurotransmitter acetylcholine, and DNA methylation. The review highlights that choline deficiency has been implicated in conditions like schizophrenia and neural tube defects, and supplementation has shown promise in mitigating symptoms of Fetal Alcohol Spectrum Disorder. With most adults consuming less than the recommended amount, the authors call for more investigation into optimal choline intake, particularly for vulnerable populations like pregnant women and preterm infants, to better define guidelines and understand the consequences of malnutrition on neurodevelopment.

On a more fundamental level, a second paper in Nature this week explores how organ-intrinsic nervous systems are built during development [6]. Using a cross-organ analysis, researchers found that the spatial layout of these systems is prefigured by the migratory paths of neural crest cells. However, their specific molecular identity is instructed by cues from the local organ environment, with the extracellular matrix playing a central role. This dual logic, where lineage sets the framework and organ signals direct the final identity, provides a new paradigm for understanding how our organs get wired up.

Our next theme shifts to the long-term consequences of the perinatal period, with two large studies examining outcomes that manifest years to decades after birth.

First, a study in Pediatric Research reports on the cardiovascular health of adults born preterm [8]. It's known that preterm birth is a risk factor for ischemic heart disease in adulthood, and this study sought to identify a potential anatomical explanation.

The Study Investigators performed cardiac MRI on a cohort of young adults who were born preterm, with an average gestational age of 27 weeks, and compared them to age-matched, term-born controls.

Results After adjusting for sex and left ventricular mass, they found that adults born preterm had significantly smaller coronary arteries. The left main, left anterior descending, and right coronary arteries all had smaller areas and diameters. This effect showed a clear dose-response relationship, with greater prematurity associated with smaller arteries. The finding was driven primarily by males born preterm, who showed substantial reductions in coronary dimensions.

Conclusions Smaller coronary artery size is a known risk factor for atherosclerosis and coronary artery disease. This finding provides a potential anatomic substrate for the increased risk of ischemic heart disease observed in adults born preterm, particularly men, and highlights the importance of long-term cardiovascular surveillance in this population.

Next, a large study in PLoS Medicine provides reassuring data on a common clinical dilemma: the use of NSAIDs during early pregnancy [4].

The Study This was a population-based retrospective cohort study in Israel, including nearly 265,000 singleton pregnancies between 1998 and 2018. The researchers evaluated the association between first-trimester exposure to prescribed NSAIDs—most commonly ibuprofen, diclofenac, and naproxen—and the risk of major congenital malformations.

Results About 7.6% of pregnancies were exposed to an NSAID in the first trimester. Using rigorous propensity score matching to adjust for a wide range of covariates, the investigators found no significant association between NSAID exposure and the overall risk of major congenital malformations. The adjusted relative risk was 0.99. Furthermore, there was no increased risk for specific organ system malformations, including cardiovascular, musculoskeletal, or central nervous system defects. A dose-response analysis also showed no significant increase in risk with short, medium, or long-term cumulative exposure.

Conclusions In this large, well-conducted study, first-trimester exposure to prescribed NSAIDs was not associated with an increased risk of major congenital malformations. This provides important, reassuring evidence for clinicians counseling pregnant patients who require treatment for pain or fever.

Our final theme covers optimizing the prevention and management of infectious diseases, with insights on vaccination, malaria, and bronchiolitis.

First, a nationwide study from Sweden published in Acta Paediatrica examines why vaccination gaps persist even in a high-resource setting [1].

The Study Researchers analyzed a cohort of over 227,000 children born in 2014 and 2015, linking the national vaccination register to socioeconomic data. They looked for risk factors for incomplete vaccination with DTP and measles-containing vaccine by age two.

Results Despite a tax-funded national immunization program, 13.1% of children had incomplete DTP vaccination and 8.7% had incomplete measles vaccination. The study confirmed known risk factors like low family income, single parenthood, parental unemployment, and frequent moves. However, it also uncovered a previously unreported risk factor: having a sibling with a disability or chronic disease. This increased the risk of incomplete vaccination by about 15% for DTP and 27% for the measles vaccine.

Conclusions Socioeconomic disparities in vaccination coverage are a reality even in systems designed for universal access. The finding that children with siblings who have complex medical needs are at higher risk suggests that family-level stressors and healthcare burden can be barriers to routine preventive care. This calls for targeted interventions to support these vulnerable families.

Turning to malaria, a post-hoc analysis in PLoS Medicine provides new clues for developing a more effective vaccine [3]. The RTS,S vaccine offers only modest protection, and understanding the immune correlates of protection is key to improving it.

The Study Investigators analyzed antibody responses from a phase IIb trial of the RTS,S vaccine in 735 young children. They looked at the fine specificity of antibodies targeting different epitopes of the circumsporozoite protein, or CSP.

Results They discovered that children who mounted a strong IgG response to two specific epitopes—a short repeat sequence called NANP2 and a cross-reactive N-terminal epitope called J1—had a significantly reduced risk of clinical malaria. For example, high IgG to the J1 epitope was associated with a nearly 30% reduction in risk. These antibody responses also correlated with higher functional activity.

Conclusions This study identifies a specific antibody signature as a new immunological correlate of protection for the RTS,S vaccine. This insight can help guide the design of next-generation malaria vaccines that are engineered to elicit this specific, protective immune response.

Finally, in the realm of acute management, a multicenter randomized trial in Archives of Disease in Childhood evaluated an automated oxygen titration system for infants with bronchiolitis [2].

The Study Across ten pediatric departments in France, 103 infants hospitalized for bronchiolitis requiring oxygen were randomized to either automated closed-loop oxygen therapy with the FreeO2 device or conventional manual oxygen titration.

Results The primary endpoint, length of hospital stay, was not significantly different between the groups, with a median of around 70 hours in both. The authors note the study may have been underpowered to detect a difference. However, there were important secondary findings. The automated FreeO2 system was significantly more effective at keeping patients within the target oxygen saturation range, achieving this 89% of the time compared to 75% with manual control. It also did so while using significantly less oxygen, with a median flow rate that was two-thirds lower than in the manual group.

Conclusions While automated oxygen titration did not shorten hospital stays in this trial, it did provide superior physiologic control and more efficient use of oxygen. This suggests the technology can improve the quality and safety of oxygen delivery for infants with bronchiolitis.

If you only have time for one paper this week, make it the case report in The New England Journal of Medicine on the neuroepithelial tumor that developed after AAV gene therapy [9]. This report of vector integration leading to oncogenesis in a human patient is a critical safety finding that will have profound implications for the development and monitoring of all gene therapies moving forward.

Here are the key takeaways from this week in Pediatrics.

First: For pregnant patients in the first trimester, new, robust data from a large cohort study suggests that NSAIDs are not associated with an increased risk of major congenital malformations, providing reassurance for their short-term use [4].

Second: Be aware that adults born preterm, especially males, may have smaller coronary arteries, a potential mechanism for their increased long-term risk of ischemic heart disease [8].

Third: Even in countries with universal healthcare, social vulnerability and having a sibling with a disability are risk factors for incomplete childhood vaccination. Consider these factors when assessing vaccination status in your patients [1].

Fourth: The field of gene therapy is advancing rapidly, with promising preclinical data for conditions like Dravet syndrome [10], but a new report of AAV-integration-associated cancer in a child highlights the critical importance of long-term safety monitoring [9].

Finally: In infants hospitalized with bronchiolitis, automated oxygen titration systems may not reduce length of stay but can improve time spent in the target saturation range while using less oxygen [2].

That's your roundup for This Week in Pediatrics. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.